Villigen, Switzerland · Founded 2019 · Privately Held (backing)
Developer of an anti-parasite technology intended to provide therapies for parasitic diseases such as malaria. ASTRA Therapeutics is based in Villigen, Switzerland and was founded in 2019. Its last reported valuation was $28 million in Jul 2025. It has raised $9.7 million.
Last reported valuation
$28.0M
Oct 2026
Priced at
—
Total raised
$9.7M
Last round
—
Cap table — not yet on record
ASTRA Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ASTRA Therapeutics with a free account
·Watch ASTRA Therapeutics: the Monday email on marks, rounds and moves
